Literature DB >> 15734207

Rectal and bladder motion during conformal radiotherapy after radical prostatectomy.

Claudio Fiorino1, Franca Foppiano, Paola Franzone, Sara Broggi, Pietro Castellone, Michela Marcenaro, Riccardo Calandrino, Giuseppe Sanguineti.   

Abstract

BACKGROUND AND
PURPOSE: To investigate the extent and the impact of rectum and bladder motion during adjuvant conformal radiotherapy (3DCRT) after radical prostatectomy (RP).
MATERIALS AND METHODS: Nine patients previously operated with RP and treated with early adjuvant 3DCRT were considered for this investigation. Weekly CT scans were collected during treatment (CT1-CTn, n=4-6) and were 3D matched using bony anatomy with the planning CT (CT0). A single observer drew the contours of rectum and bladder on all CTs. The CTV (prostate+/-seminal vesicles surgical bed) was contoured on CT0 by a single observer and a 4-field 3DCRT technique was planned: dose statistics/dose-volume histograms (DVH) of the rectum and bladder were calculated for each contour referred to CT0, CT1...CTn. Average DVHs during the treatment were then calculated and compared with the planned DVH. Cranial, caudal, anterior and posterior shifts of rectum and bladder were also assessed by lateral BEV projections. NTCP values for the rectum were also calculated using the Lyman-Kutcher model.
RESULTS: Random variations of volume and DVHs due to variable filling content were found for the bladder; a trend of the bladder to be more empty during therapy with respect to CT0 was also found (median values: 45 cm3 vs. 79 cm3, P=0.02). Regarding the rectum, 6/9 patients showed an average DVH 'worse' than the planned one (up to 10-20%). BEV and volume analyses showed that the rectal volume decreased in 3/9 patients after the first week. In 6/9 patients a systematic anterior shift of the cranial half of the rectum was detected and found to be correlated with a corresponding shift of the posterior border of CTV contoured by five different observers. The average rectal NTCP during therapy was systematically higher than the NTCP referred to CT0 (average increase 1.2%; range 0.0-3.7%, for a 70 Gy ICRU dose, P=0.01).
CONCLUSIONS: The impact of systematic uncertainty due to rectal wall motion seems to be relatively high for patients treated with adjuvant 3DCRT after RP. The detected trend of the rectum in migrating anteriorly during therapy is consistent with post-surgery settlement effects and/or some modification of rectum mobility due to irradiation. Rectal motion (and consequent shifts of CTV) was large at the half cranial portion of the rectum while it was very small below the flexure.

Entities:  

Mesh:

Year:  2004        PMID: 15734207     DOI: 10.1016/j.radonc.2004.10.002

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  17 in total

1.  Dosimetric and volumetric effects in clinical target volume and organs at risk during postprostatectomy radiotherapy.

Authors:  Ahmed Gawish; Ahmed Ali Chughtai; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2018-10-17       Impact factor: 3.621

2.  Utility of an initial adaptive bladder volume control with ultrasonography for proton-beam irradiation for prostate cancer.

Authors:  Shigeyuki Takamatsu; Kazutaka Yamamoto; Mariko Kawamura; Yoshitaka Sato; Satoko Asahi; Tamaki Kondou; Yuuji Tameshige; Yoshikazu Maeda; Makoto Sasaki; Tomoyasu Kumano; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2014-08-17       Impact factor: 2.374

3.  Adaptive radiation therapy for postprostatectomy patients using real-time electromagnetic target motion tracking during external beam radiation therapy.

Authors:  Mingyao Zhu; Shyam Bharat; Jeff M Michalski; Hiram A Gay; Wei-Hsien Hou; Parag J Parikh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-25       Impact factor: 7.038

4.  Prostate bed motion during intensity-modulated radiotherapy treatment.

Authors:  Tracy Klayton; Robert Price; Mark K Buyyounouski; Mark Sobczak; Richard Greenberg; Jinsheng Li; Lanea Keller; Dennis Sopka; Alexander Kutikov; Eric M Horwitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-11       Impact factor: 7.038

5.  Variability in bladder volumes of full bladders in definitive radiotherapy for cases of localized prostate cancer.

Authors:  Naoki Nakamura; Naoto Shikama; Osamu Takahashi; Makiko Ito; Masatoshi Hashimoto; Masahiro Uematsu; Yukihiro Hama; Kenji Sekiguchi; Keiichi Nakagawa
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

6.  Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer.

Authors:  Buelent Polat; Iris Guenther; Juergen Wilbert; Joachim Goebel; Reinhart A Sweeney; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

7.  Compliance with bladder protocol during concurrent chemoradiation for cancer of the cervix and its impact on enteritis: A prospective observational study.

Authors:  Sweta Bandanatham; Janaki Manur Gururajachar; Mohan Kumar Somashekar
Journal:  Rep Pract Oncol Radiother       Date:  2018-02-02

8.  Total error shift patterns for daily CT on rails image-guided radiotherapy to the prostate bed.

Authors:  Ronaldo Cavalieri; Hiram A Gay; Jingxia Liu; Maria C Ferreira; Helvecio C Mota; Claudio H Sibata; Ron R Allison
Journal:  Radiat Oncol       Date:  2011-10-24       Impact factor: 3.481

9.  Evaluating Variations of Bladder Volume Using an Ultrasound Scanner in Rectal Cancer Patients during Chemoradiation: Is Protocol-Based Full Bladder Maintenance Using a Bladder Scanner Useful to Maintain the Bladder Volume?

Authors:  Hong In Yoon; Yoonsun Chung; Jee Suk Chang; Joo Yong Lee; Soo Jung Park; Woong Sub Koom
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

10.  Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?

Authors:  Matthias Guckenberger; Kurt Baier; Anne Richter; Dirk Vordermark; Michael Flentje
Journal:  Radiat Oncol       Date:  2008-01-11       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.